Expert NetworkExpert InterviewGILD

Slingshot members are talking to an expert! The topic is:

A Look at the new long-term for Gilead’s Livdelzi® (seladelpar) in Primary Biliary Cholangitis (PBC)

Executed on:Jan 14, 2026 10:30 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Wisconsin
  • Professor of Gastroenterology and Hepatology at the University of Wisconsin and Director of the Metabolic Liver Health Clinic
  • Manages 80 patients with Primary Biliary Cholangitis
  • Clinical Interest in PBC and currently serves as the Program Director of the Transplant Hepatology Fellowship program at UW

Interview Goal

On this call we will be discussing the new long-term data for Gilead’s Livdelzi® (seladelpar) in primary biliary cholangitis (PBC), including sustained alkaline phosphatase reductions, improvements in chronic itch, and emerging evidence of liver stiffness stabilization or improvement from the Phase 3 ASSURE study.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.